I'm not suggesting this is the current situation, but I can't help thinking it is possible, even probable.
There is a disconnect between the Board / Management and our largest shareholder. The former want to do a deal (and there have been offers) and LW wants NEU to go it alone. The situation led to the resignation of LW's representative on the Board.
LW sees considerably more upside than what he would receive from a takeover. He also believes that he is in a position to fund the phase 3 trial.
So there is an impasse - LW has a blocking vote and the Board cannot do a deal without his approval.
- Forums
- ASX - By Stock
- NEU
- Current Scenario
NEU
neuren pharmaceuticals limited
Add to My Watchlist
2.00%
!
$16.66
Current Scenario
-
Top Stories
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
